ConforMIS develops personalized, patient-specific implants and instrumentationfor knee-related therapeutics. It is a domain having de extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, conformis.de is SAFE to browse. conformis… Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy. Conformiz specializes in business solutions which are thoughtfully designed to address the pain areas of the customer. We believe in addressing the problems of the customer at its origin; that is why we have extended our products with mobile and tablet based solutions add-ons. 08.05.2014 сущ. палеонт. похожий
The Investor Relations website contains information about ConforMIS's business for stockholders, potential investors, and financial analysts.
The CONFORMiT story has been unfolding for 30 years A pioneer in its field, CONFORMiT EHS software enables hundreds of thousands of workers across the world to work safely. We initially where looking for more systematic approach to enroll in the ISO27001 certification process. When we looked at Conformatix, it turned out they have a one-stop-shop to manage compliancy towards all our requirments and legislation, much wider then the ISO27001 we initially looked for. Conformis implants are designed individually from CT scans to fit each patient’s unique anatomy, and they are delivered in compact sterile packages with a personalized operative plan and 3D Conformis is a medical technology company that uses its proprietary iFit ® Image-to-Implant ® technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy.
ConforMIS General Information Description. Conformis Inc is a US-based medical technology company. It uses iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy.
Our ultimate goal at Conformis is to redefine the standard of care in orthopedics, but our ability to do that is only as strong as the people within. This not only applies to the technical skills required for your position, but your entrepreneurial spirit and commitment to our core values of respect for one another, collaborative teamwork, and ethical citizenship. Patient Name (last, first): Surgeon Name (last, first): Imaging Center Name: Contact Name: Contact Phone: Contact Email: Please note any issues, comments or deviations from ConforMIS protocol that may affect images: CONFORMIS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie ConforMIS Inc | A14T0Y | CFMS | US20717E1010.
Jan. 30, 2012: ConforMIS raises $89 million Series E financing round May 25, 2012: ConforMIS iTotal ® CR knee replacement system wins Silver in 2012 Medical Design Excellence Awards Oct. 3, 2012: iTotal ® G2 launched in the United States and European Union Nov. 12, 2012: Peter Traynor, a 30-year industry veteran, appointed Chief Financial Officer
conformairs.com strives, um der führende Online-Lifestyle-Einzelhändler zu sein, indem er das Beste aus Mode und Musik zu einem High-Energy-Shopping-Erlebnis macht, ohne zu Hause zu gehen. conformairs.com trägt Marken wie Nike, Adidas, diese Sneakers entworfen, um die Bewegung Ihres Fußes zu verbessern, so dass Sie mehr Freiheit mit jedem Schritt. Atraktivne kolekcije kućne dekoracije za sezonsko osveženje enterijera na velikim akcijskim popustima. 25.08.2019 ConforMIS Publikationen Updates The Journal of Knee Surgery: May 25, 2018 In Vivo Tibial Fit and Rotational Analysis of a Customized, Patient-Specific TKA versus Off-the-Shelf TKA. – Lennart Schroeder and Greg Martin The Journal of Arthroplasty, 2018 May; Volume 33, Issue 5, Epub 2017 Dec 28. Medial Overhang of the Tibial Component Is Associated With […]
Conformis and Zimmer Biomet settled disputes related to Patient-Specific Instrument Patents for Use with Off-the-Shelf Knee, Hip, and Shoulder Implants BILLERICA, Mass. , May 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license
Our ultimate goal at Conformis is to redefine the standard of care in orthopedics, but our ability to do that is only as strong as the people within. This not only applies to the technical skills required for your position, but your entrepreneurial spirit and commitment to our core values of respect for one another, collaborative teamwork, and ethical citizenship. Patient Name (last, first): Surgeon Name (last, first): Imaging Center Name: Contact Name: Contact Phone: Contact Email: Please note any issues, comments or deviations from ConforMIS protocol that may affect images: CONFORMIS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie ConforMIS Inc | A14T0Y | CFMS | US20717E1010. Zu der ConforMIS Aktie (WKN A14T0Y, ISIN US20717E1010) finden Sie hier: Analysen, News, Kurse, Charts, Diskussionen, May 31, 2017 weder Aktienoptionen noch langfristige Leistungsanreize. Verkaufte Optionen/ Swaptionen zum Marktwert. 2(d) (71.163) ConforMIS Inc. CFMS, USD, CONFORMIS INC, Log In to Check Availability Der Online-Handel mit Aktien, Optionen, Futures, Währungen, ausländischen Papieren und